Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection

Abstract Duck enteritis virus (DEV), duck tembusu virus (DTMUV), and highly pathogenic avian influenza virus (HPAIV) H5N1 are the most important viral pathogens in ducks, as they cause significant economic losses in the duck industry. Development of a novel vaccine simultaneously effective against t...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhong Zou, Kun Huang, Yanmin Wei, Huanchun Chen, Ziduo Liu, Meilin Jin
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
R
Q
Online Access:https://doaj.org/article/68c17360fa634ca7885818d33aa666d2
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:doaj.org-article:68c17360fa634ca7885818d33aa666d2
record_format dspace
spelling oai:doaj.org-article:68c17360fa634ca7885818d33aa666d22021-12-02T15:06:05ZConstruction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection10.1038/s41598-017-01554-12045-2322https://doaj.org/article/68c17360fa634ca7885818d33aa666d22017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01554-1https://doaj.org/toc/2045-2322Abstract Duck enteritis virus (DEV), duck tembusu virus (DTMUV), and highly pathogenic avian influenza virus (HPAIV) H5N1 are the most important viral pathogens in ducks, as they cause significant economic losses in the duck industry. Development of a novel vaccine simultaneously effective against these three viruses is the most economical method for reducing losses. In the present study, by utilizing a clustered regularly interspaced short palindromic repeats (CRISPR)/associated 9 (Cas9)-mediated gene editing strategy, we efficiently generated DEV recombinants (C-KCE-HA/PrM-E) that simultaneously encode the hemagglutinin (HA) gene of HPAIV H5N1 and pre-membrane proteins (PrM), as well as the envelope glycoprotein (E) gene of DTMUV, and its potential as a trivalent vaccine was also evaluated. Ducks immunized with C-KCE-HA/PrM-E enhanced both humoral and cell-mediated immune responses to H5N1 and DTMUV. Importantly, a single-dose of C-KCE-HA/PrM-E conferred solid protection against virulent H5N1, DTMUV, and DEV challenges. In conclusion, these results demonstrated for the first time that the CRISPR/Cas9 system can be applied for modification of the DEV genome rapidly and efficiently, and that recombinant C-KCE-HA/PrM-E can serve as a potential candidate trivalent vaccine to prevent H5N1, DTMUV, and DEV infections in ducks.Zhong ZouKun HuangYanmin WeiHuanchun ChenZiduo LiuMeilin JinNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Zhong Zou
Kun Huang
Yanmin Wei
Huanchun Chen
Ziduo Liu
Meilin Jin
Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
description Abstract Duck enteritis virus (DEV), duck tembusu virus (DTMUV), and highly pathogenic avian influenza virus (HPAIV) H5N1 are the most important viral pathogens in ducks, as they cause significant economic losses in the duck industry. Development of a novel vaccine simultaneously effective against these three viruses is the most economical method for reducing losses. In the present study, by utilizing a clustered regularly interspaced short palindromic repeats (CRISPR)/associated 9 (Cas9)-mediated gene editing strategy, we efficiently generated DEV recombinants (C-KCE-HA/PrM-E) that simultaneously encode the hemagglutinin (HA) gene of HPAIV H5N1 and pre-membrane proteins (PrM), as well as the envelope glycoprotein (E) gene of DTMUV, and its potential as a trivalent vaccine was also evaluated. Ducks immunized with C-KCE-HA/PrM-E enhanced both humoral and cell-mediated immune responses to H5N1 and DTMUV. Importantly, a single-dose of C-KCE-HA/PrM-E conferred solid protection against virulent H5N1, DTMUV, and DEV challenges. In conclusion, these results demonstrated for the first time that the CRISPR/Cas9 system can be applied for modification of the DEV genome rapidly and efficiently, and that recombinant C-KCE-HA/PrM-E can serve as a potential candidate trivalent vaccine to prevent H5N1, DTMUV, and DEV infections in ducks.
format article
author Zhong Zou
Kun Huang
Yanmin Wei
Huanchun Chen
Ziduo Liu
Meilin Jin
author_facet Zhong Zou
Kun Huang
Yanmin Wei
Huanchun Chen
Ziduo Liu
Meilin Jin
author_sort Zhong Zou
title Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
title_short Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
title_full Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
title_fullStr Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
title_full_unstemmed Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection
title_sort construction of a highly efficient crispr/cas9-mediated duck enteritis virus-based vaccine against h5n1 avian influenza virus and duck tembusu virus infection
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/68c17360fa634ca7885818d33aa666d2
work_keys_str_mv AT zhongzou constructionofahighlyefficientcrisprcas9mediatedduckenteritisvirusbasedvaccineagainsth5n1avianinfluenzavirusandducktembusuvirusinfection
AT kunhuang constructionofahighlyefficientcrisprcas9mediatedduckenteritisvirusbasedvaccineagainsth5n1avianinfluenzavirusandducktembusuvirusinfection
AT yanminwei constructionofahighlyefficientcrisprcas9mediatedduckenteritisvirusbasedvaccineagainsth5n1avianinfluenzavirusandducktembusuvirusinfection
AT huanchunchen constructionofahighlyefficientcrisprcas9mediatedduckenteritisvirusbasedvaccineagainsth5n1avianinfluenzavirusandducktembusuvirusinfection
AT ziduoliu constructionofahighlyefficientcrisprcas9mediatedduckenteritisvirusbasedvaccineagainsth5n1avianinfluenzavirusandducktembusuvirusinfection
AT meilinjin constructionofahighlyefficientcrisprcas9mediatedduckenteritisvirusbasedvaccineagainsth5n1avianinfluenzavirusandducktembusuvirusinfection
_version_ 1718388587282563072